Baloxavir Impurity 35 CAS CATO-C4X-210835
| CAS No. | CATO-C4X-210835 |
| Molecular Formula | C10H11N3O4 |
| Molecular Weight | 237.21 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Baloxavir Impurity 35 is closely related to an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Baloxavir Impurity 35 (CAS CATO-C4X-210835), a pharmacopoeial impurity reference standard (molecular formula C10H11N3O4, MW 237.21 g/mol) used for the identification and quantification of trace impurities in APIs.
Structurally, Baloxavir Impurity 35 (C10H11N3O4) contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 7.0, corresponding to approximately 7 ring(s) or double-bond equivalent(s). With a molecular weight of 237.21 g/mol, it falls into the medium-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C10H11N3O4 |
| Molecular Weight | 237.21 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (faint amine-like odor) |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 7.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 3 |
Related Baloxavir Standards
- Baloxavir impurity 85 (CAS 2708125-86-2)
- Baloxavir Impurity 119 (CAS CATO-C4X-2108119)
- Baloxavir Marboxil Impurity 235 (CAS CATO-C4X-2108235)
- Baloxavir Impurity 24 (CAS 2365473-57-8)
- Baloxavir Impurity 30 (CAS 119736-16-2)
- Baloxavir Impurity 18 (CAS 1820001-72-6)
- Baloxavir Marboxil Impurity 191 (CAS 1820002-36-5)
- Baloxavir Marboxil Impurity 203 (CAS CATO-C4X-2108203)
Recommended Standards
- Polaprezinc Impurity 3 (CAS 103646-38-4)
- Barloxavir impurity 81 (CAS 2814504-20-4)
- Oseltamivir Impurity 132 (CAS 162252-43-9)
- Metoclopramide Impurity 89 (CAS CATO-C4X-141589)
- Tegoprazan Impurity 78 (CAS CATO-C4X-229778)
- Vitamin A impurity 26 (CAS CATO-C4X-218726)
- Loxoprofen Impurity 82 (CAS CATO-C4X-148882)
- N-(3-aminophenyl)-3-chlorobenzamide (CAS 293737-89-0)
- 1142204-45-2 9302AC C18H18Cl2N2O4 [{2-[(2,4-Dichlorobenzyl)amino]-2-oxoethyl}-(4-methoxyphenyl)amino]acetic acid (CAS 1142204-45-2)
- 2-((4'-Bromo-[1,1'-biphenyl]-4-yl)sulfinyl)acetamide (CAS 3393-79-1)
- (R)-7-amino-5-azaspiro[2.4]heptan-4-one (CAS 328405-11-4)
- tert-Butyl 4-acetoxypiperidine-1-carboxylate (CAS 850452-53-8)
- 4-Chloro-6-fluoro -2-(trifluoromethyl)-1H-benzimidazole (CAS 89426-97-1)
- Tirzepatide Impurity 24 X TFA Salt (CAS CATO-C4X-324024)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com